State Street Corporation 13D and 13G filings for Akebia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-20 08:55 am Sale | 2022-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | STATE STREET CORP STT | 571,936 0.310% | -11,171,525 (-95.13%) | Filing |
| 2022-02-10 1:23 pm Sale | 2021-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | STATE STREET CORP STT | 11,743,461 6.710% | -2,263,176 (-16.16%) | Filing |
| 2021-07-12 10:45 am Sale | 2021-06-30 | 13G | Akebia Therapeutics, Inc. AKBA | STATE STREET CORP STT | 14,006,637 8.750% | -8,469,897 (-37.68%) | Filing |
| 2021-02-11 12:43 pm Sale | 2020-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | STATE STREET CORP STT | 22,476,534 15.550% | -340,636 (-1.49%) | Filing |
| 2021-02-10 10:26 am Purchase | 2021-01-31 | 13G | Akebia Therapeutics, Inc. AKBA | STATE STREET CORP STT | 22,817,170 15.790% | 7,476,699 (+48.74%) | Filing |